@article{3c73826764f54c9da20a6a3cc89c84f6,
title = "An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough",
abstract = " Blocking NMDA receptors with memantine in refractory chronic cough patients is poorly tolerated and demonstrates no improvement in cough https://bit.ly/3kgx2g1. ",
author = "Rayid Abdulqawi and Imran Satia and Holt, {Kimberley J} and Rachel Dockry and Shilpi Sen and Smith, {Jaclyn A}",
note = "Funding Information: Conflict of interest: R. Abdulqawi reports personal fees from AstraZeneca, Boehringer Ingelheim and Mundipharma outside the submitted work. I. Satia reports personal fees from educational talks for GPs from GSK and AstraZeneca, grants and personal fees from Merck Canada, and an ERS Respire 3 Marie Curie Fellowship, outside the submitted work. K.J. Holt has nothing to disclose. R. Dockry has nothing to disclose. S. Sen has nothing to disclose. J.A. Smith reports grants and personal fees from GSK, NeRRe Pharmaceuticals, Menlo, Bayer, Boehringer Ingleheim, Axalbion, Afferent and Merck; personal fees from Genentech, Neomed, Bellus, Chiesi, AstraZeneca and Algernon; and nonfinancial support from Vitalograph, all outside the submitted work. In addition, J.A. Smith has a patent (A method for generating output data) licensed. Funding Information: Support statement: The Medical Research Council as part of a fellowship award made to J.A. Smith. J.A. Smith is funded by the NIHR Manchester Biomedical Research Centre and a Wellcome Investigator Award (207504/B/17/Z), and is an NIHR Senior Investigator. I. Satia is currently supported by the E.J. Moran Campbell Early Career Award, Dept of Medicine, McMaster University. Funding information for this article has been deposited with the Crossref Funder Registry.",
year = "2021",
month = jul,
day = "29",
doi = "10.1183/23120541.00447-2021",
language = "English",
volume = "7",
journal = "ERJ Open Research",
issn = "2312-0541",
publisher = "European Respiratory Society",
number = "3",
}